Evidence map›Paper›PMID 41246301›Full record

ReviewFrontiers in immunology2025

Response to anaplastic lymphoma kinase inhibitor in gastric cancer harboring

Huadi Wang, Liangkun You, Hong Pan, Xiaotong Qiu, Jin Sheng

Abstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Huadi WangDepartment of Medical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou, China.
Liangkun YouDepartment of Medical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou, China.
Hong PanDepartment of Medical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou, China.
Xiaotong QiuDepartment of Medical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou, China.
Jin ShengDepartment of Medical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anaplastic lymphoma kinase (

Indexed as

AdenocarcinomaAnaplastic Lymphoma KinaseCarbazolesMicrotubule-Associated ProteinsOncogene Proteins, FusionProtein Kinase InhibitorsStomach NeoplasmsFemaleHumansMiddle AgedPiperidinesTreatment OutcomealectinibALK protein, humanAnaplastic Lymphoma KinaseCarbazolesMicrotubule-Associated ProteinsOncogene Proteins, FusionPiperidinesProtein Kinase Inhibitorsanaplastic lymphoma kinase (ALK)case reportcirculating tumor DNA (ctDNA)next generation sequencing (NGS)review

Identifiers

PMID41246301
PMCPMC12611845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.